Premium
When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the ‘Australian guidelines for the management of cutaneous melanoma’
Author(s) -
Gyorki David E,
Barbour Andrew,
Hanikeri Mark,
Mar Victoria,
Sandhu Shahneen,
Thompson John F
Publication year - 2017
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/ajd.12662
Subject(s) - medicine , melanoma , sentinel lymph node , biopsy , sentinel node , lymph node , radiology , dermatology , general surgery , pathology , cancer , breast cancer , cancer research
A sentinel lymph node biopsy is a surgical staging procedure performed for patients with primary cutaneous melanoma who are clinically lymph‐node negative to determine whether there is low volume nodal metastasis in the draining lymph node field. A systematic review was recently performed to update the Australian clinical practice guidelines for the diagnosis and management of melanoma, addressing the question, ‘When is a sentinel lymph node biopsy indicated?’ This article discusses the findings of the systematic review and the evidence base for the updated guidelines.